To assess a potential memory response for long-term tumour control, mice cured from LLC1-IFNAR1−/− tumours by VSV-GP therapy (survival >80 days) were re-challenged via contralateral subcutaneous injection of parental or IFNAR1-deficient LLC1 cells and monitored for tumour outgrowth. The gene discussed is IFNAR1; the disease is neoplasm.